Repeated lab results
The same tests over months or years (HbA1c every quarter, kidney function every year): the change over time is what research learns from.
Worth, per test result
$0.24
How it is pricedGiven by uploading a document; the AI reads it into your file.
Patients usually have it with
Iron deficiency anaemiaKidney stonesLeukaemiaMyasthenia gravisPulmonary fibrosisHepatitis BSchizophreniaRheumatoid arthritisHeart failureCrohn's diseasePreeclampsiaHypothyroidismType 1 diabetesChronic kidney diseaseGoutMenopauseThyroid cancerCoronary heart diseaseType 2 diabetesGestational diabetesFatty liver diseaseEating disordersBipolar disorderColorectal cancerCystic fibrosisDepressionLupusPCOSProstate cancerSickle cell diseaseStrokeHIV
Evidence about it (44)
- Blood count monitoring for recurrent IDARecords patients typically holdperhaps every 6 months initially
- Haemoglobin check for response to oral ironRecords patients typically holdin the first 4 weeks
- 24-hour urine collection (metabolic evaluation)Records patients typically holdevery twelve months
- Blood count and physical examination while early-stage chronic lymphocytic leukaemia is watchedRecords patients typically hold3- to 12-monthly controls by blood count
- Blood count and liver function monitoring on azathioprineRecords patients typically holdregular monitoring
- Lung function tests (spirometry and gas transfer)Records patients typically holddiagnosis and 6 months and 12 months after diagnosis
- HBV DNA, quantitative HBsAg and HBeAg status on tenofovirRecords patients typically holdthen every 6 months
- Full blood count, liver and renal function, and phosphate on tenofovirRecords patients typically holdthen every 3 months
- Fasting blood glucose or HbA1c, and blood lipids, on antipsychotic medicationRecords patients typically holdat 12 weeks, at 1 year and then annually
- CRP blood test and DAS28 disease activity scoreRecords patients typically holdmonthly in specialist care until remission or low disease activity
- Kidney function and electrolytes blood testRecords patients typically holdevery 3 to 6 months once the maximum tolerated dose has been established
- Blood monitoring for azathioprine, mercaptopurine or methotrexateRecords patients typically holdas advised in the BNF
- Full blood count, liver function and renal function blood testsRecords patients typically holdtwice a week
- TSH blood test on levothyroxineRecords patients typically holdevery 3 months until stable, then once a year
- Kidney tests (eGFR and urine albumin:creatinine ratio)Records patients typically holdannually, with cardiovascular risk assessment
- HbA1c testRecords patients typically holdevery 3 to 6 months
- Urine albumin:creatinine ratio (ACR)Records patients typically holdindividualised by risk of progression
- eGFR blood testRecords patients typically holdminimum number of checks per year depends on GFR and ACR category
- GFR monitoring for people on kidney-affecting medicinesRecords patients typically holdat least annually
- Annual serum urate monitoring on urate-lowering therapyRecords patients typically holdannual
- Serum urate blood tests while urate-lowering therapy is titratedRecords patients typically holdmonthly
- Two FSH blood tests to diagnose premature ovarian insufficiency (under 40)Records patients typically hold2 blood samples taken 4 to 6 weeks apart
- Thyroglobulin and thyroglobulin antibody blood testsRecords patients typically hold3- to 6-month intervals in the first 2 years ... 6- to 12-month intervals thereafter
- Full lipid profileRecords patients typically holdannually
- HbA1c testRecords patients typically holdevery 3 to 6 months until stable, then every 6 months
- Annual HbA1c test after gestational diabetesRecords patients typically holdan annual HbA1c test
- Home capillary blood glucose readings (fasting and 1-hour post-meal)Records patients typically holddaily
- Repeat ELF test for people with an ELF score below 10.51Records patients typically holdevery 3 years to adults every 2 years to children and young people
- Annual physical and mental health review with relevant blood tests (anorexia nervosa not in treatment)Records patients typically holdat least annually
- Annual physical health check blood tests (HbA1c or fasting glucose, lipid profile, liver, renal and thyroid function)Records patients typically holdat least annually
- Plasma lithium levelRecords patients typically holdweekly until the levels are stable
- CEA blood test follow-upRecords patients typically holdfor the first 3 years
- Cystic-fibrosis-related diabetes testRecords patients typically holdannually from 10 years of age
- Weight, renal and thyroid function and calcium levels while on lithiumRecords patients typically holdat least every 6 months
- Blood cholesterol and glucose (cardiovascular risk check)Records patients typically holdat least once a year
- Routine labs in inactive disease: blood count, ESR, CRP, albumin, creatinine or eGFR, urinalysis, urine protein/creatinine ratioRecords patients typically holdAt 6–12 months intervals
- Protein/creatinine ratio, C3, C4, anti-dsDNA, urine microscopy and blood pressure in lupus nephropathyRecords patients typically holdat least every 3 months for the first 2–3 years
- Glycaemic status test (OGTT, fasting glucose or HbA1c)Records patients typically holdevery one to three years
- PSA on intermittent androgen deprivation therapyRecords patients typically holdmeasure PSA every 3 months
- PSA blood test after radical treatmentRecords patients typically holdat least every 6 months for the first 2 years, and then at least once a year
- Blood count with differential and reticulocytes on hydroxyureaRecords patients typically holdat least every 4 weeks
- Urine protein screenRecords patients typically holdrepeat screening annually
- Blood glucose readings during the acute stroke admissionRecords patients typically holdbetween 4 and 11 mmol/litre
- HIV viral load test on antiretroviral therapyRecords patients typically holdby six months, at 12 months and then every 12 months thereafter